Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) EBITDA Margin (2024)

Incannex Healthcare's EBITDA Margin history spans 1 years, with the latest figure at 52566.67% for Q4 2024.

  • On a quarterly basis, EBITDA Margin changed N/A to 52566.67% in Q4 2024 year-over-year; TTM through Jun 2025 was 54302.33%, a N/A change, with the full-year FY2025 number at 54302.33%, up 10016434.0% from a year prior.
  • EBITDA Margin hit 52566.67% in Q4 2024 for Incannex Healthcare, down from 6866.22% in the prior quarter.
  • Over the last five years, EBITDA Margin for IXHL hit a ceiling of 6866.22% in Q3 2024 and a floor of 52566.67% in Q4 2024.